RxDoctor Payments Data

Selena Sheppard, PA

Physician Assistant · Walled Lake, MINPI 1295491041

Payments from drug & device makers

$1,315in general payments, 2019–2025

Across 65 payments — averaging $20.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$322
  • AstraZeneca$234
  • Pfizer$214
  • Lilly USA, LLC$142
  • Exact Sciences$57
  • Phathom Pharmaceuticals, Inc.$42
  • plus $304 from 13 others

What the payments were for

  • Food & beverage$1,315100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,315 in reported general payments places this provider in the 75th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$30,570
Medicare patients
126
Services billed
1,902

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide22$19,900
FarxigaDapagliflozin Propanediol12$19,156
JardianceEmpagliflozin20$15,949
MounjaroTirzepatide13$14,680
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$12,921
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$9,996
Albuterol Sulfate HfaAlbuterol Sulfate55$1,551
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$1,376
Atorvastatin Calcium91$1,064
Omeprazole30$946
Levothyroxine Sodium75$944
Rosuvastatin Calcium65$891
Pantoprazole Sodium52$796
Metoprolol Succinate30$790
Lisinopril56$523

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$142$34,58035 claims
AstraZenecaFarxiga, Breztri Aerosphere$234$29,15324 claims
Boehringer IngelheimJardiance$25$15,94920 claims
GSKTrelegy Ellipta$33$12,92111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Walled Lake

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →